214 related articles for article (PubMed ID: 7524921)
1. Stage II nonseminomatous germ-cell testicular tumors--the Indiana experience and risk-benefit analysis.
Foster RS; Bihrle R; Little JS; Rowland RG; Donohue JP
World J Urol; 1994; 12(3):143-6; discussion 147. PubMed ID: 7524921
[TBL] [Abstract][Full Text] [Related]
2. Evolution and controversies in the management of low-stage nonseminomatous germ-cell tumors of the testis.
Pizzocaro G; Nicolai N; Salvioni R
World J Urol; 1994; 12(3):113-9. PubMed ID: 7524920
[TBL] [Abstract][Full Text] [Related]
3. The role of retroperitoneal lymphadenectomy in clinical stage B testis cancer: the Indiana University experience (1965 to 1989).
Donohue JP; Thornhill JA; Foster RS; Bihrle R; Rowland RG; Einhorn LH
J Urol; 1995 Jan; 153(1):85-9. PubMed ID: 7966799
[TBL] [Abstract][Full Text] [Related]
4. Laparoscopic retroperitoneal lymph node dissection combined with adjuvant chemotherapy for pathological stage II disease in nonseminomatous germ cell tumours: a 15-year experience.
Cresswell J; Scheitlin W; Gozen A; Lenz E; Teber D; Rassweiler J
BJU Int; 2008 Sep; 102(7):844-8. PubMed ID: 18537954
[TBL] [Abstract][Full Text] [Related]
5. [Efficacy of modified retroperitoneal lymph node dissection for testicular nonseminomatous germ cell tumors].
Liu ZW; Zhou FJ; Han H; Qin ZK; Yu SL; Li YH; Ye YL; Teng XY
Ai Zheng; 2008 Dec; 27(12):1302-6. PubMed ID: 19079998
[TBL] [Abstract][Full Text] [Related]
6. Nonrandomized comparison of primary chemotherapy and retroperitoneal lymph node dissection for clinical stage IIA and IIB nonseminomatous germ cell testicular cancer.
Stephenson AJ; Bosl GJ; Motzer RJ; Bajorin DF; Stasi JP; Sheinfeld J
J Clin Oncol; 2007 Dec; 25(35):5597-602. PubMed ID: 18065732
[TBL] [Abstract][Full Text] [Related]
7. Testicular cancer.
Nichols CR
Curr Probl Cancer; 1998; 22(4):187-274. PubMed ID: 9743088
[TBL] [Abstract][Full Text] [Related]
8. Stage I nonseminomatous germ-cell testicular cancer--management options and risk-benefit considerations.
Donohue JP; Thornhill JA; Foster RS; Rowland RG; Bihrle R
World J Urol; 1994; 12(4):170-6; discussion 177. PubMed ID: 7820136
[TBL] [Abstract][Full Text] [Related]
9. Randomized phase III trial comparing retroperitoneal lymph node dissection with one course of bleomycin and etoposide plus cisplatin chemotherapy in the adjuvant treatment of clinical stage I Nonseminomatous testicular germ cell tumors: AUO trial AH 01/94 by the German Testicular Cancer Study Group.
Albers P; Siener R; Krege S; Schmelz HU; Dieckmann KP; Heidenreich A; Kwasny P; Pechoel M; Lehmann J; Kliesch S; Köhrmann KU; Fimmers R; Weissbach L; Loy V; Wittekind C; Hartmann M;
J Clin Oncol; 2008 Jun; 26(18):2966-72. PubMed ID: 18458040
[TBL] [Abstract][Full Text] [Related]
10. Cisplatin-based chemotherapy after retroperitoneal lymph node dissection in patients with pathological stage II nonseminomatous germ cell tumors.
Culine S; Theodore C; Farhat F; Bekradda M; Terrier-Lacombe MJ; Droz JP
J Surg Oncol; 1996 Mar; 61(3):195-8. PubMed ID: 8637206
[TBL] [Abstract][Full Text] [Related]
11. Cost and risk benefit in the management of clinical stage II nonseminomatous testicular tumors.
Baniel J; Roth BJ; Foster RS; Donohue JP
Cancer; 1995 Jun; 75(12):2897-903. PubMed ID: 7773940
[TBL] [Abstract][Full Text] [Related]
12. Management of patients with clinical stage I or II nonseminomatous germ cell tumors of the testis. Evolving therapeutic options.
Richie JP; Socinsky MA; Fung CY; Brodsky GL; Kalish LA; Garnick MB
Arch Surg; 1987 Dec; 122(12):1443-5. PubMed ID: 2446590
[TBL] [Abstract][Full Text] [Related]
13. Surgical treatment of patients with stages I and II nonseminomatous testicular cancer.
Fraley EE; Narayan P; Vogelzang NJ; Kennedy BJ; Lange PH
J Urol; 1985 Jul; 134(1):70-3. PubMed ID: 2409301
[TBL] [Abstract][Full Text] [Related]
14. Etoposide and cisplatin adjuvant therapy for patients with pathologic stage II germ cell tumors.
Motzer RJ; Sheinfeld J; Mazumdar M; Bajorin DF; Bosl GJ; Herr H; Lyn P; Vlamis V
J Clin Oncol; 1995 Nov; 13(11):2700-4. PubMed ID: 7595727
[TBL] [Abstract][Full Text] [Related]
15. Clinical stage I nonseminomatous germ cell tumors of the testis in childhood and adolescence: an analysis of 31 cases.
Terenziani M; Piva L; Spreafico F; Salvioni R; Massimino M; Luksch R; Cefalo G; Casanova M; Ferrari A; Polastri D; Mazza E; Bellani FF; Nicolai N
J Pediatr Hematol Oncol; 2002; 24(6):454-8. PubMed ID: 12218592
[TBL] [Abstract][Full Text] [Related]
16. Nonseminomatous germ cell tumors of the testis: current concepts and controversies.
Sheinfeld J
Urology; 1994 Jul; 44(1):2-14. PubMed ID: 7518979
[No Abstract] [Full Text] [Related]
17. RPLND or primary chemotherapy in clinical stage IIA/B nonseminomatous germ cell tumors? Results of a prospective multicenter trial including quality of life assessment.
Weissbach L; Bussar-Maatz R; Flechtner H; Pichlmeier U; Hartmann M; Keller L
Eur Urol; 2000 May; 37(5):582-94. PubMed ID: 10765098
[TBL] [Abstract][Full Text] [Related]
18. Treatment of Relapse of Clinical Stage I Nonseminomatous Germ Cell Tumors on Surveillance.
Hamilton RJ; Nayan M; Anson-Cartwright L; Atenafu EG; Bedard PL; Hansen A; Chung P; Warde P; Sweet J; O'Malley M; Sturgeon J; Jewett MAS
J Clin Oncol; 2019 Aug; 37(22):1919-1926. PubMed ID: 30802156
[TBL] [Abstract][Full Text] [Related]
19. The value of prognostic factors in the management of stage I nonseminomatous germ cell testicular tumors (NSGCTT).
Ondrus D; Goncalves F; Kausitz J; Mat'oska J; Belan V
Neoplasma; 1996; 43(3):195-7. PubMed ID: 8841507
[TBL] [Abstract][Full Text] [Related]
20. Quality-of-Life Analysis of the German Prospective Multicentre Trial of Single-cycle Adjuvant BEP Versus Retroperitoneal Lymph Node Dissection in Clinical Stage I Nonseminomatous Germ Cell Tumours.
Flechtner HH; Fischer F; Albers P; Hartmann M; Siener R;
Eur Urol; 2016 Mar; 69(3):518-25. PubMed ID: 26620368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]